Sanofi shares slide as FDA delays MS drug decision and late-stage trial disappoints

Shares of French pharmaceutical group Sanofi fell sharply on Monday after the company flagged another delay to a US regulatory decision for its experimental multiple sclerosis drug tolebrutinib and re... ...